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Surgical treatment decision making in 
breast cancer among Chinese women: 
participation and satisfaction
Key Messages
1. Chinese women do not want to 
make breast cancer treatment 
decisions alone.
2. Most women left to make a 
decision with no input from their 
surgeon feel over-involved.
3. Over-involved women have 
greater difficulty making decis-
ions and are less confident about 
their treatment choice.
4. Knowing their  surgeon’s 
preferred surgical option is 
important to Hong Kong Chinese 
women. Therefore, surgeons 
should outline the choices then 
give a recommendation.
5. Once made the woman’s choice 
should be respected.
Hong Kong Med J 2007;13(Suppl 3):S15-8
Introduction
While patient participation in health care may confer a sense of control, it makes 
the patient assume responsibility for outcomes, which is stressful. Some women 
with breast cancer want to leave treatment decision making (TDM) solely to their 
surgeons, but most prefer to be involved.1 Participation preferences (PP) in breast 
cancer TDM are influenced by education1 and age2 but are dependant on doctors 
providing the opportunity to choose. Studies examining the congruence between 
preferred and actual levels of TDM involvement in breast cancer surgery report 
that 28 to 50% of women fail to achieve their desired level of involvement.3 Older 
women2,3 and those of lower socio-economic status4 are less likely to achieve 
their desired level of TDM involvement. Participation congruence impacts on 
patient outcomes: more incongruence predicts less satisfaction with a medical 
consultation. Increasing involvement has little value unless the patient perceives 
it as preferable and beneficial. Most studies of patient participation in breast 
cancer TDM have been done on Caucasian women. We examined Hong Kong 
Chinese women’s preferences for, and actual participation in breast cancer TDM, 
the influences on PP, perceived participation congruence (PPC), and the effect of 
reported participation incongruence on satisfaction with TDM.
Methods
Sample and setting
This study was conducted from October 2000 to June 2003. Between October 2001 
and April 2002, 211 Chinese women newly diagnosed with breast cancer underwent 
surgical treatment in six government-funded hospitals in Hong Kong. Inclusion 
criteria were age 20 years or older and Cantonese fluency. Exclusion criteria were 
linguistic or intellectual difficulties, a currently active Axis I psychiatric diagnosis, 
or uncontrolled metastatic brain disease. Of these 211 women, 22 did not meet the 
inclusion criteria, and 17 were inaccessible. Therefore, 172 women were invited 
to participate and 154 agreed, giving a response rate of 89.5%.
Procedure
Following ethical approval, medical records were reviewed to confirm eligibility. 
Eligible women were approached and given an explanation of the study and 
information on: participants’ rights, uncontested and unprejudiced withdrawal, 
and anonymity safeguards. Written informed consent was obtained from each 
participant. Interviews were conducted in private, by one of three trained 
interviewers, within 12 days of surgery.
Measures
Perceived involvement in treatment decision making
Three items were used to measure perceived involvement in TDM: “Did your 
surgeon tell you there were treatment options?” assessed opportunity for surgical 
choice. “Did you feel you had a choice about which type of surgery to have?” 
measured perception of control over the treatment choice. A choice of one of 
the following measured how involved they felt they were in the TDM: “No 
participation”, “Much less than I wanted”, “About as much as I wanted”, and “I was 
left to decide everything though I didn’t want to”. Finally, women indicated whether 
their surgeons had communicated a preference for a particular type of surgery.
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Treatment decision making participation preferences
Women indicated their PP in TDM by choosing one of 
the following options: active (I wanted it to be fully my 
decision), collaborative (I wanted it to be partly my decision 
and partly someone else’s), or passive (I wanted someone 
else to make the decision). Those preferring collaborative 
or passive roles indicated who they wanted to help them 
decide. To assess the clarity and content validity of these 
items they were reviewed by a breast nurse specialist and 
a breast surgeon and piloted on 10 randomly chosen Hong 
Kong Chinese women following breast cancer surgery.
Perceived treatment decision making difficulties
The Perceived Treatment Decision Making Difficulties 
Scale is a qualitatively and quantitatively derived eight-item 
instrument that was piloted on 226 Chinese women following 
breast cancer treatment.5 This four-point Likert-scored scale 
comprises two sub-scales: a ‘barriers’ subscale comprising 
six items assessing decision making difficulties and a 
‘facilitators’ subscale comprising two items that facilitate 
treatment decision making. Women also rated their level of 
confidence in their treatment choice on a 10-cm line marked 
“0% No chance–––––––––100% Completely certain”.
Patient satisfaction with the medical consultation
We used a modified version of the Cognitive and the 
Affective sub-scales of the Medical Interview Satisfaction 
Scale5 to measure satisfaction with the TDM consultation. 
To minimise the assessment load, only the four most relevant 
items from each subscale were used. The modified instru-
ment was revalidated on 82 Hong Kong Chinese women 
following breast cancer treatment. For each of the eight state-
ments, respondents were asked to recall the medical consult-
ation that led to their treatment decision. A total satisfaction 
score was obtained by combining the two sub-scale scores.
Demographic and medical information
Information obtained from hospital charts included: cancer 
stage, time since surgery, type of surgery, and type of adju-
vant therapy including radiation therapy, chemotherapy, and
hormonal therapy. Demographic information included patient’s
age, marital status, number of children, income, current house-
hold size, education, occupation, residency, and religion.
Statistical analysis
One-way ANOVA was used to test the effect of age on TDM 
PP, and PPC. Kendall’s tau was used to test associations 
between education and both PP and PPC, and associations 
between TDM PP and PPC. A Chi squared test was used 
to test differences in PPC by (1) presence or absence of 
surgeon’s expressed preference for surgery type and (2) 
opportunity to choose between breast conserving treatment 
(BCT) and modified radical mastectomy (MRM). In those 
offered a choice between BCT and MRM, the Chi squared 
test was used to evaluate differences in PPC according to 
women’s perception of control over their treatment choice. 
Stepwise multiple linear regressions examined the effect 
of PPC on their TDM satisfaction. The Statistical Package 
for the Social Sciences (Windows version 10.0; SPSS Inc, 
Chicago [IL], US) was used.
Results
Sample characteristics
The 154 participants, aged 28 to 79 (mean, 51.76; standard 
deviation [SD], 11.09) years were mostly married 
(73%), had at least a secondary education (56%), and 
were employed full-time (37%). The rest were mostly 
housewives (25%) and retirees (21%). At baseline, 17 
(11%) were previously employed and nine (6%) became 
unemployed after the diagnosis of breast cancer. Of 
these 154 women, 108 (70%) had MRM, 30 (19%) had 
BCT, and 13 (8%) had MRM plus breast reconstruction 
(MRM+R). Two (1%) had BCT followed later by MRM. 
One had an axillary dissection only. Of the 108 women 
with known staging information, 19 (18%) had stage 
0 cancer, 30 (28%) had stage I, and 53 (49%) stage II. 
The time since diagnosis ranged from less than 1 month 
to 10 months (mean, 2.18; median, 2; SD, 1.69 months); 
42% had surgery within 1, and 76% within 2 months of 
diagnosis. Neochemotherapy (given before surgery to 
shrink the tumour) was associated with more advanced 
disease (χ2 for trend=7.3, P<0.001), prompting delays of 
4 months or more between diagnosis and surgery (χ2 for 
trend=51.6, P<0.001), but referral or hospital source did 
not affect delay. Women were interviewed between 1 and 
12 days (mean, 2.97; SD, 1.87 days) post surgery.
Women’s perceptions of treatment decision making 
involvement
Eighty-four (55%) women were offered different surgical 
options and 43 (51%) indicated that their surgeons expressed 
a preference for surgery type. Of the 84 women offered a 
choice, 61 (73%) perceived that they truly had a choice of 
surgery type, while 23 (27%) perceived that they “really had 
no choice”. Of these, 11 (48%) indicated that their medical 
condition dictated the decision for them and nine (39%) 
indicated that their surgeons implied one treatment was 
superior. Eventually, of the 84 women offered a choice, 50 
(60%) chose MRM, 28 (33%) BCT, and six (7%) MRM+R. 
Forty-one (49%) made an immediate choice, with 27 (66%) 
choosing MRM, one (2%) MRM+R, and 13 (32%) BCT. 
Of the women encouraged to delay their decision, 23 (53%) 
chose MRM, 5 (12%) MRM+R, and 15 (35%) BCT.
Education Participation preference, No. (%)
Active Collaborative Passive
No formal education 8 (47) 8 (47) 1 (6)
Primary 17 (33) 29 (57) 5 (10)
Secondary 21 (31) 41 (61) 5 (8)
Tertiary 5 (26) 13 (68) 1 (5)
Total 51 (33) 91 (59) 12 (8)






Table 1.  Women’s treatment decision making participation 
preferences (n=154)
* Analysis of variance, F=4.01, df=2,151, P=0.02
† Post hoc Bonferroni mean difference=8.76, P=0.029
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Treatment decision making participation preference
Fifty-one (33%) women wanted sole responsibility for the 
decision, 91 (59%) wished to share the decision with some-
one else, and 12 (8%) wanted to delegate the decision. The 
surgeon and the spouse were the people most often nomin-
ated to share the decision, or delegated to make it. Preferred 
decision making roles only differed by age (F=4.01, df=2,
P=0.02): women preferring a collaborative role were younger 
(mean age, 50.1 years) than those preferring a passive role 
(mean age, 58.8 years) [mean difference, 8.8 years; P=0.029 
post hoc Bonferroni] (Table 1). The TDM participation pre-
ference was neither affected by any delay between diag-
nosis and treatment nor by immediate versus delayed choice.
Perceived participation congruence in treatment 
decision making
A total of 124 (81%) women felt they had participated as 
much as they desired, 20 (13%) felt they had participated 
more than they desired (over-involved), and 10 (6%) felt 
they were not allowed to participate or had participated 
less than they desired (not-at-all– or under-involved). 
The PPC did not differ with age, education, time from 
diagnosis to treatment, nor by immediate versus delayed 
choice, however PPC did differ between women whose 
surgeons had expressed a preference for surgery type and 
women whose surgeons had not expressed a preference 
(χ2=6.63, df=2, P=0.036). More of those whose surgeons 
had not expressed a preference (23%) felt that they were 
over-involved than those whose surgeons had expressed a 
preference (9%). Differences were also found between PPC 
and the offer of treatment choice. More of those women not 
offered treatment choices (11%) felt that they were not-at-
all–, or under-involved compared to those offered treatment 
choices (2%). In contrast, more of those offered treatment 
choices (22%) felt over-involved than those with no 
choices (3%) [χ2=15.59, df=2, P<0.000]. These data did not 
support the hypothesis that PPC is a function of women’s 
perception of control over their treatment choice; in this 
group PPC was unrelated to the perception that they really 
had a choice. The PP level and PPC were not significantly 
correlated (Table 2).
Effect of perceived participation congruence on 
patient treatment decision making satisfaction
Perceived participation congruence significantly predicted 
perceived TDM difficulty, adjusting for age. Compared 
with those who felt they had participated about as much 
as they desired, women who felt either over-involved 
(β=0.21, P=0.009) or under-involved (β=0.16, P=0.045) 
reported significantly greater difficulties making treatment 
decisions. Decision Barriers and Decision Facilitators sub-
scale scores were significantly predicted by PPC. Compared 
to women who felt they had participated about as much 
as they desired, women who felt over-involved perceived 
greater barriers (β=0.19, P=0.021) and fewer facilitators 
(insufficient time and information) [β=0.16, P=0.04] to 
making a treatment decision. Compared to women who 
felt they had participated about as much as they desired, 
those who felt not-at-all– or under-involved perceived 
fewer facilitators (β=0.33, P<0.000) when making their 
treatment decision. Adjusting for the effects of other 
variables, neither the Medical Interview Satisfaction Scale
nor sub-scale scores were predicted by PPC. Overall, women 
in each of the three PPC categories were satisfied with 
their medical consultation (mean score, 31.55; SD, 4.22). 
Perceived participation congruence significantly predicted 
perceived confidence in having made the right treatment 
choice. Women who felt over-involved had significantly 
less confidence (β= –0.23, P=0.005) that they had made 
the right treatment choice compared with those who felt 
Perceived participation congruence, No. (%)
Not allowed/less than desired As much as desired More than desired
Education
No formal education 1 (6) 11 (65) 5 (29)
Primary 5 (10) 39 (76) 7 (14)
Secondary 3 (4) 59 (88) 5 (7)
Tertiary 1 (5) 15 (79) 3 (16)
Surgeon expressed surgical 
preference*
Yes 9 (8) 91 (83) 10 (9)
No 1 (2) 32 (74) 10 (23)
Treatment choices offered†
Yes 2 (2) 63 (76) 18 (22)
No 8 (11) 61 (86) 2 (3)
Participation preference
Active 0 46 (90) 5 (10)
Collaborative 8 (9) 68 (75) 15 (16)
Passive 2 (17) 10 (83) 0 
Perception of control over 
treatment choice (n=84)
Yes 0 48 (79) 13 (21)
No 2 (9) 16 (70) 5 (22)
Total 10 (6) 124 (80) 20 (13)
Mean age (SD) [years] 47.2 (11.5) 52.1 (11.4) 51.6 (8.8)
Table 2.  Women’s perceptions of participation congruence in decision making (n=154)
* χ2=6.63, df=2, P=0.036
† χ2=15.59, df=2, P<0.000
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they had participated about as much as they desired. There 
was no significant difference (P=0.09) between the under-
involved group and the as-much-as-desired group regarding 
confidence in the right treatment choice.
Discussion
Breast cancer TDM preferences vary nationally and 
temporally. Our validated methods are highly relevant to 
Hong Kong Chinese women. Participants were interviewed 
after their surgery, permitting bias from cognitive dissonance 
particularly the post hoc rationalisation of decisional choice. 
To minimise this, we interviewed women early (mean time, 
day 3 post surgery). Surgical wounds are usually covered for 
a few days post-surgery, and anatomical pathology results 
may not be available for up to 4 weeks hence, participants’ 
responses were unlikely to be contaminated by regret or 
disappointment over outcomes. There is the possibility that 
pain, analgesia or in some cases residual anaesthetic effects 
might have influenced reporting.
 Participants preferred to be involved in breast cancer 
TDM, but two thirds preferred a shared rather than sole 
responsibility, consistent with earlier reports.6 However, 
if the choice is between either the woman or the doctor 
deciding, then women prefer that their doctor makes 
the choice, under the assumption that doctors are better 
informed.5 Participants preferred a moderated active role if 
they were asked to choose between active, collaborative, 
and passive roles. This suggests that most Hong Kong 
Chinese women want shared responsibility with their 
doctors when making a treatment decision and do not 
want to be left to make their decisions alone. Older women 
preferred a passive role, probably reflecting paternalistic 
traditions of care.2,7 In Hong Kong, older women tend to 
be less formally educated and may lack confidence in their 
choices. Even so, few women preferred a passive role, 
which might explain why, unlike previous studies, we 
found education to be unrelated to PPC.1 Those women 
not offered treatment options felt under-involved, finding 
TDM more difficult. Those feeling over-involved perceived 
more barriers to their TDM. A similar US study8 reported 
PPC rates of 49% congruent, 25% under-involved and 26% 
over-involved, compared with our rates of 80%, 6% and 
13% respectively. Knowing their surgeon’s preference for 
type of surgery is important to Hong Kong Chinese women. 
Those who did not know this preference felt over-involved. 
These data indicate complexities in TDM choice roles and 
have implications for clinical care of Hong Kong Chinese 
women with breast cancer. If women who prefer shared 
decision making are left to decide alone, more time and 
information will not benefit them. Over-involved women 
face greater difficulties with decision making and have less 
confidence in their treatment choices, a possible source of 
unnecessary stress.
 This study has several implications for clinicians 
managing Hong Kong Chinese women with breast cancer. 
When discussing treatment options, clinicians should: 
suggest that decision making be shared but offer the option 
of either party deciding; ask the woman to express her 
feelings about being offered a treatment option; respect a 
preference, once expressed. It is also important to: ensure 
the woman has enough time to ask questions and to make 
a treatment decision; encourage the woman to repeat the 
discussion to ensure she has understood the content; give her 
time (24-72 hours) to decide and to be available to answer 
questions; express your own preference for treatment, eg 
“If you were my sister/wife/mother/daughter…” or “If I 
were in your position, I’d probably want to have MCM/
BCT, etc” and say why.9
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